Remove 2024 Remove Management Remove Provider Remove Specialization
article thumbnail

Assessment of Project ECHO(R) Opioid Use Disorder Sessions for Primary Care Teams [Education and training]

Annals of Family Medicine

A critical shortage of clinicians who specialize in treating patients with OUD exacerbates this issue. While primary care (PC) settings have the potential to bridge this gap in care, many care teams lack the education and training required to effectively manage patients with OUD.

article thumbnail

Episode 354: Antiracism in Medicine – Episode 25 – Live from SGIM 2024: Best of Antiracism Research at the Society of General Internal Medicine’s 2024 Annual Meeting

The Clinical Problem Solvers

[link] CPSolvers: Anti-Racism in Medicine Series Episode 25 – Live from SGIM 2024: Best of Antiracism Research at the Society of General Internal Medicine’s 2024 Annual Meeting Show Notes by Ashley M. September 19, 2024. During this episode, we hear from Dr. S. Zakaria, S., Vaught, A. Toth-Manikowski, S. M., & Smith, G.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Dedicated ICU management: Navigating the transition

Sound Physicians

For hospitals, this means investing in cutting-edge medical interventions and partnerships that help them transition to the modern best-practice of dedicated ICU management. For smaller or rural hospitals, this can mean supplementing patient care with tele-ICU clinicians, available 24/7, to keep our providers from stretching too thin.

article thumbnail

Deprescribing Super Special III: Constance Fung, Emily McDonald, Amy Linsky, and Michelle Odden

GeriPal

Summary Transcript CME Summary Its another deprescribing super special on today’s GeriPal Podcast, where we delve into the latest research on deprescribing medications prescribed to older adults. Eric 00:04 And Alex, we ve got another deprescribing super special with us today. This is Eric Widera. Alex 00:03 This is Alex Smith.

article thumbnail

AI/ML-enabled Medical Devices Have Everyone’s Attention, Including FDA’s

FDA Law

Gonzalez — The Wall Street Journal (WSJ) recently published a series of articles as part of its special report “What’s Ahead for Artificial Intelligence.” Just a day earlier, FDA’s Center for Devices and Radiological Health (CDRH) released a list of the guidance documents the Center intends to publish in the upcoming 2024 fiscal year.

Medical 119
article thumbnail

It’s the Law Now –Cybersecurity Information in Premarket Submissions

FDA Law

Congress has given FDA the authority to require device manufacturers to provide cybersecurity information in their premarket submissions for a “cyber device.” It will be provided in a future eSTAR update. Now, with explicit statutory authority, FDA’s push for cybersecurity has a firm legal footing.

article thumbnail

At Long Last, FDA Unveils Plan for Rare Disease Innovation Hub

FDA Law

Importantly, the Hub is intended to establish a new model within FDA, which leverages cross-Agency expertise in providing guidance and conducting reviews for products for rare disease populations. By Sarah Wicks & James E. Valentine & Frank J. those reviewed by the CDER Division of Rare Diseases and Medical Genetics).